Today: 19 March 2026
Subscribe
Browse Category

NASDAQ:ANAB 10 January 2026 - 11 January 2026

GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

GSK stock: $50m Noetik deal and Jemperli royalty lawsuit sharpen focus on Feb 4 results

AnaptysBio filed a motion to dismiss part of GSK’s claim in a Delaware court dispute over royalties from cancer drug Jemperli. The court is expected to hear the motion by early March, with trial set for July. GSK ADRs closed up 0.3% at $50.39 in New York; London shares slipped 0.26% to 1,886 pence. Investors await GSK’s Jan. 13 conference appearance and Feb. 4 results.
10 January 2026
····

Stock Market Today

  • Indian Markets Plunge Nearly 2,500 Points Amid Crude Spike and Global Concerns
    March 19, 2026, 10:32 AM EDT. Indian stock markets recorded their worst decline since June 2024. The Sensex dropped nearly 2,500 points while the Nifty approached 23,000. Market capitalization fell by over ₹11.5 lakh crore in one session. The selloff was driven by rising crude oil prices caused by tensions in West Asia, hawkish signals from the U.S. Federal Reserve indicating potential interest rate hikes, and foreign investor outflows. These factors combined to increase near-term volatility concerns among investors.
Go toTop